Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Sepúlveda-Crespo, D; Sánchez-Merino, V; Amigot-Sánchez, R; Rubio-Pérez, A; Díez, C; Hontañón, V; Berenguer, J; González-García, J; García, F; Martínez, I; Yuste, E; Resino, S.

Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis

Vaccines. 2025; 13(5): [doi:10.3390/vaccines13050539]

Grinspoon, SK; Watanabe, M; Ribaudo, HJ; Bloomfield, GS; Fichtenbaum, CJ; Umbleja, T; Chu, SM; Fitch, K; Diggs, MR; Zhao, SP; Looby, SE; Currier, JS; Aberg, JA; Malvestutto, CD; Erlandson, KM; Martinez, E; Asupoto, O; Gupta, SK; de Quiros, JCLB; Nixon, D; Bedimo, R; Lu, MT; Douglas, PS; Zanni, M.

Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With Human Immunodeficiency Virus (HIV)

CLINICAL INFECTIOUS DISEASES. 2025; : Nº de citas: 7 [doi:10.1093/cid/ciaf210]

Muñoz-Gómez, MJ; Ryan, P; Quero-Delgado, M; Martin-Vicente, M; Cuevas, G; Valencia, J; Jiménez, E; Blanca-López, N; Manzano, S; Lazo, JI; Mas, V; Vázquez, M; Sepúlveda-Crespo, D; Torres-Macho, J; Martínez, I; Resino, S.

Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination

Vaccines. 2025; 13(5): Nº de citas: 1 [doi:10.3390/vaccines13050480]

Pérez-Valero, I; Mata, DC; Espejo, AC; Gallo, M; de Morales, AGGR; Fanciulli, C; Martín-Carbonero, L; Isbert, SC; Gutiérrez, CH; Asensi, V; Juarez, AR; Rivero, A.

Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With Human Immunodeficiency Virus Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort-The ACTUAS II Study

CLINICAL INFECTIOUS DISEASES. 2025; : Nº de citas: 1 [doi:10.1093/cid/ciaf162]

Ollero, MJF; Ryan, P; Dolengevich-Segal, H; Cano-Smith, J; Ramos-Ruperto, L; Cabello, A; Sanchez-Conde, M; Cabello, N; Sanz, J; García-Fraile, LJ; Perez-Latorre, L; Bisbal, O; de la Fuente, S; Losa, JE; González-Baeza, A.

Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as Predictors

AIDS AND BEHAVIOR. 2025; 29(7): 2324-2335 Nº de citas: 4 [doi:10.1007/s10461-025-04695-x]

Bailón, L; Moltó, J; Curran, A; Cadiñanos, J; de Quirós, JCLB; de los Santos, I; Ambrosioni, J; Imaz, A; Benet, S; Suanzes, P; Navarro, J; González-García, J; Busca, C; Pérez-Latorre, L; Berenguer, J; García-Fraile, LJ; Mejia-Abril, G; Miró, JM; Scévola, S; Moreno, S; Domingo, P; Tian, Y; Frankot, M; Lim, D; Cai, YH; Vendrame, E; Guo, S; Wallin, JJ; Geleziunas, R; Sengupta, D; Alarcón-Soto, Y; Leal, I; Aranguen, A; Garcia-Garcia, M; McGowan, I; Brander, C; Arribas, JR; Mothe, B.

Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial

Nature Communications. 2025; 16(1): Nº de citas: 20 [doi:10.1038/s41467-025-57284-w]

De la Villa S; Parras V; Pérez-Latorre L; Martín-Rabadán P.

An exceptional cause of brain abscess.

Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2025; 43(3): 177-178 [doi:10.1016/j.eimce.2024.09.012]

Tejerina, F; Peñas-Utrilla, D; Herranz, M; Catalán, P; Marín, M; Mesones, L; García-Domínguez, JM; Merino, B; Pérez, L; Fanciulli, C; Muñoz, P; Rodríguez-Gonzalez, C; Diez, C; Aldámiz, T; Molero-Salinas, A; Pérez-Lago, L; de Viedma, DG.

Chronic Systemic SARS-CoV-2 Infection Without Respiratory Involvement in an Immunocompromised Patient

Viruses-Basel. 2025; 17(2): [doi:10.3390/v17020147]

Aldámiz-Echevarria, T; Fanciulli, C; Lopez, M; Perez, L; Tejerina, F; Sanchez, D; Lodeiros, B; López, JC; Berenguer, J; Bellon, JM; Ferris, M; Blazquez, M; Calvo, A; Domene, M; Vegas, O; Rodriguez, C; Muñoz, P; Gijon, P; Montilla, P; Bermudez, E; Valerio, M; Alonso, R; Padilla, B; Ventimilla, C; Diez, C.

Direct collaboration between hospitals and NGOs, an essential tool to reinforce linkage to care in people living with HIV

Scientific Reports. 2025; 15(1): [doi:10.1038/s41598-025-86540-8]

Virseda-Berdices, A; Brochado-Kith, O; Berenguer, J; González-García, J; Pérez-Latorre, L; Busca, C; Díez, C; Micán, R; Fernández-Rodríguez, A; Jiménez-Sousa, MA; Resino, S.

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients

Frontiers in Pharmacology. 2025; 15: [doi:10.3389/fphar.2024.1436198]

Izquierdo, R; Suárez-García, I; Marco-Sánchez, C; Pérez-Latorre, L; Riera, M; Cano, J; Viladés, C; Reus, S; Olalla, J; González-Ruano, P; Orviz, E; Díaz, A; Moreno, S; Jarrín, I; CoRIS cohort.

Health-related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short-term changes over time

HIV MEDICINE. 2025; 26(4): 606-620 [doi:10.1111/hiv.13762]

Virseda-Berdices, A; Martín-Escolano, R; Berenguer, J; González-García, J; Brochado-Kith, O; Rojo, D; Díez, C; Hontañon, V; Pérez-Latorre, L; Ibañez-Samaniego, L; Llop-Herrera, E; Olveira, A; Fernández-Rodríguez, A; Barbas, C; Resino, S; Jimenez-Sousa, MA; ESCORIAL Study Grp.

Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients

LIVER INTERNATIONAL. 2025; 45(1): Nº de citas: 2 [doi:10.1111/liv.16204]

Harney, BL; Sacks-Davis, R; van Santen, DK; Stewart, AC; Matthews, GV; Carson, JM; Klein, MB; Lacombe, K; Wittkop, L; Salmon, D; Leleux, O; Merchadou, L; van der Valk, M; Smit, C; Prins, M; Boyd, A; Berenguer, J; Jarrin, I; Rauch, A; Hellard, ME; Doyle, JS.

Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort

LIVER INTERNATIONAL. 2025; 45(1): 1-13 [doi:10.1111/liv.16203]

Martín-Escolano, R; Virseda-Berdices, A; Berenguer, J; González-Garcia, J; Brochado-Kith, O; Fernández-Rodríguez, A; Díez, C; Hontañon, V; Resino, S; Jimenez-Sousa, MA; Marathon Study Grp.

Immune checkpoint proteins are associated with persistently high liver stiffness after successful HCV treatment in people with HIV: a retrospective study

Frontiers in Immunology. 2024; 15: Nº de citas: 1 [doi:10.3389/fimmu.2024.1505864]

Treviño-Nakoura, A; Sepúlveda-Crespo, D; Bellon, JM; Codina, H; Quero-Delgado, M; Ryan, P; Martínez, I; Resino, S.

Diagnostic performance of hepatitis C virus core antigen testing for detecting hepatitis C in people living with hepatitis B: a systematic review and meta-analysis

Infectious Diseases of Poverty. 2024; 13(1): Nº de citas: 2 [doi:10.1186/s40249-024-01264-7]

Chacón, F; Morano, L; Navarro, J; Granados, R; Llibre, JM; Ryan, P; Aldámiz-Echevarria, T; Carbonero, LM; Puigvehi, M; Clotet-Codina, I; Sanchez-Vega, N; Vacas, E; Rincón, O; Berenguer, J; Crespo, J; Roncero, C.

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study

BMC PUBLIC HEALTH. 2024; 24(1): Nº de citas: 4 [doi:10.1186/s12889-024-20625-3]

Martín-Escolano, R; Virseda-Berdices, A; Berenguer, J; González-García, J; Brochado-Kith, O; Fernández-Rodríguez, A; Díez, C; Hontañon, V; Resino, S; Jiménez-Sousa, MA.

Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study

Frontiers in Pharmacology. 2024; 15: Nº de citas: 1 [doi:10.3389/fphar.2024.1341612]

Ryan, P; Valencia, J; Sepúlveda-Crespo, D; Amigot-Sánchez, R; Cuevas, G; Lazarus, JV; Pérez-García, F; Martínez, I; Resino, S.

Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain

JAMA Network Open. 2024; 7(10): Nº de citas: 3 [doi:10.1001/jamanetworkopen.2024.38657]